Hologic, Inc. announced that Nanaz Mohtashami has been elected to the Company’s Board of Directors, effective September 20, 2023. Ms. Mohtashami was also appointed to the Compensation Committee and the Nominating and Corporate Governance Committee effective September 20, 2023.

 

Ms. Mohtashami is a Managing Director at Russell Reynolds Associates, a leading executive search and leadership advisory firm, where she heads their global Med Tech, Devices & Diagnostics Practice. Ms. Mohtashami joined Russell Reynolds in November 2013 and held various roles of increasing responsibility before becoming a Managing Director in June 2018. Prior to joining Russell Reynolds, Ms. Mohtashami spent 13 years as a strategy consultant with Monitor Group, advising leading clients both in the UK and around the globe.

 

“It is a pleasure to welcome Nanaz to our Board,” said Steve MacMillan, Hologic’s Chairman, President and Chief Executive Officer. “Her exceptional background in both global strategy and deep experience in the broader healthcare sector, combined with her strong team orientation, make her yet another strong addition to our board.”

 

Ms. Mohtashami holds a BA and M.Eng. from Cambridge University and a Master of Business Administration from INSEAD.

 

Source: Hologic

«« The Need to Address Missed and Delayed Cancer Screenings During the Pandemic


New Findings Aimed at Improving Post-Screening Follow-Up Rates »»



Latest Articles

Nanaz Mohtashami,Hologic ,Board of Directors Hologic, Inc. announced that Nanaz Mohtashami has been elected to the Company’s Board of Directors, effective September 20, 2023. Ms. Mohtashami was als...